Cargando…
Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study
Objectives: Network pharmacological methods were used to investigate the underlying molecular mechanisms of LianXia NingXin (LXNX) formula, a Chinese prescription, to treat coronary heart disease (CHD) and disease phenotypes (CHD related diseases and symptoms). Methods: The different seed gene lists...
Autores principales: | Yang, Yang, Yang, Kuo, Hao, Teng, Zhu, Guodong, Ling, Ruby, Zhou, Xuezhong, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952186/ https://www.ncbi.nlm.nih.gov/pubmed/29867541 http://dx.doi.org/10.3389/fphys.2018.00489 |
Ejemplares similares
-
LianXia Formula Granule Attenuates Cardiac Sympathetic Remodeling in Rats with Myocardial Infarction via the NGF/TrKA/PI3K/AKT Signaling Pathway
por: Li, Sai-Sai, et al.
Publicado: (2021) -
A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Ban-Xia-Xie-Xin-Tang
por: Yang, Ming, et al.
Publicado: (2018) -
Investigation of the Cellular Pharmacological Mechanism and Clinical Evidence of the Multi-Herbal Antiarrhythmic Chinese Medicine Xin Su Ning
por: Ma, Yu-ling, et al.
Publicado: (2020) -
Prevalence of the Metabolic Syndrome among rural original adults in NingXia, China
por: Yi, Zhao, et al.
Publicado: (2010) -
A Network Pharmacology Study of the Multi-Targeting Profile of an Antiarrhythmic Chinese Medicine Xin Su Ning
por: Wang, Taiyi, et al.
Publicado: (2019)